A new prospective study has found that initiating continuous glucose monitoring (CGM) at the point of hospital discharge is associated with significantly improved glycemic control and may halve the risk of hospital readmission for patients with type 2 diabetes. The research, published in Journal of the Endocrine Society , suggests that providing patients with real-time data during the high-risk transition from inpatient to home care is both feasible and safe.
This clinical “bridge” addresses a long-standing gap in diabetes management where patients often struggle to maintain the stability achieved under professional supervision once they return to their daily routines. The study, “ Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes ,” conducted by researchers at The Ohio State University Wexner Medical Center, focused on 108 hospitalized adults with poorly controlled type 2 diabetes (HbA1c > 8.0%) who required basal insulin therapy.
By equipping participants with a Dexcom G6 CGM system upon leaving the hospital, clinicians were able to monitor their transition over a 12-week period.
Endocrine News published a clinical update in Research Highlights on 08 Apr 2026.
The item focuses on Continuous Glucose Monitoring Cuts Readmission Risks.
Review the original article for the full source wording and details.